Open access
Sep 2026
Computational design of potent, broadly neutralizing anti-Nipah virus and Hendra virus miniproteins
The prototype members of the genus Henipavirus, Nipah virus (NiV) and Hendra virus (HeV), cause recurrent zoonotic spillovers with case fatality rates ranging from 40-90% in humans. Currently, there are no approved vaccines or therapeutics for use in humans. Neutralizing antibodies targeting the NiV/HeV F-or G-glycopro...
J. Sims, Risako Gen, Kaitlin R. Sprouse et al.
· bioRxiv · 0 citations